Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journal/vegf-cox-2-and-pcna-expression-in-renal-cell-carcinoma-subtypes-and-TNnNpWMQ1w
References (36)
-
J. Jacobsen, K. Grankvist, T. Rasmuson, Anders Bergh, G. Landberg, B. Ljungberg (2004)
Expression of vascular endothelial growth factor protein in human renal cell carcinomaBJU International, 93
-
D. Dewitt, W. Smith (1995)
Yes, but do they still get headaches?Cell, 83
-
P. Hall, D. Levison, A. Woods, C. Yu, D. Kellock, J. Watkins, D. Barnes, C. Gillett, R. Camplejohn, R. Dover, N. Waseem, D. Lane (1990)
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 162
-
O. Gallo, E. Masini, B. Bianchi, L. Bruschini, M. Paglierani, A. Franchi (2002)
Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.Human pathology, 33 7
-
Kathleen Leahy, A. Koki, J. Masferrer (2000)
Role of cyclooxygenases in angiogenesis.Current medicinal chemistry, 7 11
-
B. Delahunt, P. Bethwaite, J. Nacey, J. Ribas (1993)
Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: Comparison with tumour grade, mitotic index, and silver‐staining nucleolar organizer region numbersThe Journal of Pathology, 170
-
N. Waseem, D. Lane (1990)
Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.Journal of cell science, 96 ( Pt 1)
-
D. Bates, T. Cui, J. Doughty, M. Winkler, M. Sugiono, J. Shields, D. Peat, D. Gillatt, S. Harper (2002)
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.Cancer research, 62 14
-
S. Fuhrman, L. Lasky, C. Limas (1982)
Prognostic significance of morphologic parameters in renal cell carcinomaThe American Journal of Surgical Pathology, 6
-
G. Kovacs, M. Akhtar, B. Beckwith, P. Bugert, C. Cooper, B. Delahunt, J. Eble, S. Fleming, B. Ljungberg, L. Medeiros, H. Moch, V. Reuter, E. Ritz, G. Roos, D. Schmidt, J. Srigley, S. Störkel, E. Berg, B. Zbar (1997)
The Heidelberg classification of renal cell tumoursThe Journal of Pathology, 183
-
P. Larsson, G. Roos, R. Stenling, B. Ljungberg (1996)
Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.Scandinavian journal of urology and nephrology, 30 6
-
I. Shameem, T. Shimabukuro, T. Wada, H. Kurisu, K. Naito (1996)
Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.European urology, 29 1
-
E. Fosslien (2001)
Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.Annals of clinical and laboratory science, 31 4
-
H. Gerber, K. Hillan, A. Ryan, J. Kowalski, G. Keller, Linda Rangell, Barbara Wright, F. Radtke, M. Aguet, N. Ferrara (1999)
VEGF is required for growth and survival in neonatal mice.Development, 126 6
-
D. Cho, H. Joo, D. Oh, J. Kang, Y. Kim, K. Lee, S. Kim (2005)
Cyclooxygenase-2 and p53 Expression as Prognostic Indicators in Conventional Renal Cell CarcinomaYonsei Medical Journal, 46
-
E. Warbrick (2000)
The puzzle of PCNA's many partnersBioEssays, 22
-
N. Weidner, J. Semple, W. Welch, J. Folkman (1991)
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.The New England journal of medicine, 324 1
-
A. Ristimäki, O. Nieminen, K. Saukkonen, K. Hotakainen, S. Nordling, C. Haglund (2001)
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.The American journal of pathology, 158 3
-
H. Yokogi (1996)
Flow cytometric quantitation of the proliferation‐associated nuclear antigen p105 and DNA content in patients with renal cell carcinomaCancer, 78
-
R. Stein, Bhanu Gupta, S. Agarwal, J. Golub, D. Bhutani, A. Rosman, C. Eng (2008)
Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome.The American journal of cardiology, 102 5
-
J. Jacobsen, T. Rasmuson, K. Grankvist, B. Ljungberg (2000)
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.The Journal of urology, 163 1
-
C. Fischer, C. Georg, S. Kraus, H. Terpe, G. Luedecke, W. Weidner (1999)
CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma.Anticancer research, 19 2C
-
P. Carmeliet, D. Collen (2000)
Transgenic mouse models in angiogenesis and cardiovascular diseaseThe Journal of Pathology, 190
-
Brett Delahunt (1998)
Histopathologic prognostic indicators for renal cell carcinoma.Seminars in diagnostic pathology, 15 1
-
K. Cronin, N. Williams, M. Kerin, T. Creagh, P. Dervan, J. Smith, J. Fitzpatrick (1994)
Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma.The Journal of urology, 152 3
-
Y. Hashimoto, Y. Kondo, G. Kimura, I. Matsuzawa, S. Sato, M. Ishizaki, N. Imura, M. Akimoto, S. Hara (2004)
Cyclooxygenase‐2 expression and relationship to tumour progression in human renal cell carcinomaHistopathology, 44
-
B. Rini, V. Weinberg, Sarah Dunlap, A. Elchinoff, N. Yu, R. Bok, J. Simko, E. Small (2006)
Maximal COX‐2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinomaCancer, 106
-
B. Ljungberg, J. Jacobsen, Stina Häggström-Rudolfssson, T. Rasmuson, G. Lindh, K. Grankvist (2003)
Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinomaUrological Research, 31
-
Y. Yasunaga, M. Shin, Tsuneharu Miki, A. Okuyama, K. Aozasa (1998)
Prognostic factors of renal cell carcinoma: A multivariate analysisJournal of Surgical Oncology, 68
-
A. Cassoni (1987)
Tnm Classification of Malignant Tumours -
Y. Miyata, S. Koga, S. Kanda, M. Nishikido, Tomayoshi Hayashi, H. Kanetake (2003)
Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 5
-
E. Fosslien (2000)
Molecular pathology of cyclooxygenase-2 in neoplasia.Annals of clinical and laboratory science, 30 1
-
E. Fosslien (2000)
Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in NeoplasiaCritical Reviews in Clinical Laboratory Sciences, 37
-
Qinzhong Chen, N. Shinohara, T. Abe, Takafumi Watanabe, K. Nonomura, T. Koyanagi (2004)
Significance of COX‐2 expression in human renal cell carcinoma cell linesInternational Journal of Cancer, 108
-
D. Nicol, S. Hii, Michael Walsh, Bin Teh, L. Thompson, Colin Kennett, D. Gotley (1997)
Vascular endothelial growth factor expression is increased in renal cell carcinoma.The Journal of urology, 157 4
-
R. Yoshimura, M. Matsuyama, Y. Kawahito, K. Tsuchida, K. Kuratsukuri, Y. Takemoto, M. Mitsuhashi, H. Sano, T. Nakatani (2004)
Study of cyclooxygenase-2 in renal cell carcinoma.International journal of molecular medicine, 13 2
- Publisher
- Springer Journals
- Copyright
- Copyright © 2008 by Springer Science+Business Media, B.V.
- Subject
- Medicine & Public Health; Nephrology; Urology
- ISSN
- 0301-1623
- eISSN
- 1573-2584
- DOI
- 10.1007/s11255-008-9362-7
- pmid
- 18324478
- Publisher site
- See Article on Publisher Site
Abstract
It is obvious that prognostic factors such as VEGF, COX-2, and PCNA may vary depending on histological subtype. The level of expression of these factors together with histological subtype may provide valuable predictive information about the outcome of treatment.
Journal
International Urology and Nephrology – Springer Journals
Published: Mar 7, 2008